COMPANY / NEON DEVELOPMENT
OKYO Pharma
: OKYO · Database-backed coverage
OK
OKYO Pharma
: OKYO · America/Chicago
13latest headcount
0active jobs
7tracked employees
New · 7 days
0
Closed · 7 days
0
Net · 7 days
0
Changed postings
0
AI company brief
AI-generated interpretation
Company sources
1 configured| Provider | Source | Enabled |
|---|---|---|
| bright_data | Open source ↗ | enabled |
Collector configuration
Job adapterdisabled
Workforce providerbright_data
Schedule hour6:00 America/Chicago
Tracked employees
Owned by signed-in user| Employee | Job title / function | Source profile | Latest observation | State | Recent change |
|---|---|---|---|---|---|
Afshin Aminolshari FCCA | Finance Manager | bright_data ↗ | OKYO Pharma · Unknown role | Successfully observed | None observed |
Amelia Eleanor | Not configured | bright_data ↗ | Unknown · Unknown role | Source unavailable | None observed |
Gary S Jacob, PhD | Chief Development Officer | bright_data ↗ | OKYO Pharma · Unknown role | No material change | None observed |
Kristi Chase | Principal Scientist, Computational Biology | bright_data ↗ | OKYO Pharma · Unknown role | Successfully observed | None observed |
Kristie Russ Veasey | Executive Director, Clinical Development | bright_data ↗ | OKYO Pharma · Unknown role | No material change | None observed |
Raj Patil, Ph.D. | Chief Scientific Officer | bright_data ↗ | OKYO Pharma · Unknown role | No material change | None observed |
Robert Dempsey | Chief Executive Officer | bright_data ↗ | OKYO Pharma · Unknown role | No material change | None observed |
Headcount history
16 observations13latest
0latest change
-2observed range
| Observed | Headcount | Change | Source | Confidence |
|---|---|---|---|---|
| Oct 12, 2026, 1:01 AM CDT | 13 | 0 (0.00%) | bright_data | high |
| Oct 11, 2026, 1:01 AM CDT | 13 | 0 (0.00%) | bright_data | high |
| Oct 10, 2026, 1:01 AM CDT | 13 | 0 (0.00%) | bright_data | high |
| Oct 9, 2026, 1:02 AM CDT | 13 | 0 (0.00%) | bright_data | high |
| Oct 8, 2026, 1:02 AM CDT | 13 | -1 (-7.14%) | bright_data | high |
| Oct 7, 2026, 1:01 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 6, 2026, 1:01 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 5, 2026, 1:03 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 4, 2026, 1:01 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 3, 2026, 1:01 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 2, 2026, 1:01 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Oct 1, 2026, 1:04 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Sep 30, 2026, 1:02 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Sep 29, 2026, 1:05 AM CDT | 14 | 0 (0.00%) | bright_data | high |
| Sep 28, 2026, 1:02 AM CDT | 14 | -1 (-6.67%) | bright_data | high |
| Sep 27, 2026, 1:03 AM CDT | 15 | Baseline | bright_data | high |
Employee observation history
Most recent 25| Employee | Observed | Employer / role | Employment dates | State | Confidence |
|---|---|---|---|---|---|
Gary S Jacob, PhD | Oct 11, 2026, 1:01 AM CDT | OKYO Pharma · Unknown role | Unavailable | No material change | high |
Robert Dempsey | Oct 10, 2026, 1:01 AM CDT | OKYO Pharma · Unknown role | Unavailable | No material change | high |
Afshin Aminolshari FCCA | Oct 9, 2026, 1:03 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Kristi Chase | Oct 8, 2026, 1:02 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Amelia Eleanor | Oct 7, 2026, 1:02 AM CDT | Unknown employer · Unknown role | Unavailable | Source unavailable | low |
Raj Patil, Ph.D. | Oct 6, 2026, 1:01 AM CDT | OKYO Pharma · Unknown role | Unavailable | No material change | high |
Kristie Russ Veasey | Oct 5, 2026, 1:03 AM CDT | OKYO Pharma · Unknown role | Unavailable | No material change | high |
Gary S Jacob, PhD | Sep 30, 2026, 1:02 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Robert Dempsey | Sep 29, 2026, 1:05 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Raj Patil, Ph.D. | Sep 28, 2026, 1:03 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Kristie Russ Veasey | Sep 27, 2026, 1:03 AM CDT | OKYO Pharma · Unknown role | Unavailable | Successfully observed | high |
Job mix
| Function | Active jobs |
|---|---|
| No function classifications are available. | |
| Geography | Active jobs |
|---|---|
| No geography classifications are available. | |
| Business category | Active jobs |
|---|---|
| No business classifications are available. | |
| Clearance | Active jobs |
|---|---|
| No clearance classifications are available. | |
| Work mode | Active jobs |
|---|---|
| No work-mode classifications are available. | |
Recent closures
| Posting | Closed |
|---|---|
| No jobs have been confirmed closed. | |
Recent changed postings
| Change | Detected | Notification |
|---|---|---|
| No material posting changes are recorded. | ||
Recent postings
| Posting | Function | Location | First seen |
|---|---|---|---|
| No jobs have been collected for this company. | |||